WIPO trademark

FIRVANQ

RegisteredWIPOClass 5

"FIRVANQ" is a trademark owned by Azurity Pharmaceuticals, Inc., filed at the WIPO on April 9, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Azurity Pharmaceuticals, Inc. portfolioGet this data via the API
FIRVANQ
Trademark as filed with the WIPO
Status
Registered
Filed
April 9, 2025
Registered
Not yet
Expires
April 9, 2035
Application no.
Not recorded
Registration no.
1854723
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
1 class
Ownership

Who owns FIRVANQ

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Azurity Pharmaceuticals, Inc.

United States

32 trademarks in the portfolioView company

Representative

Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.

Douglas R. Wolf Wolf, Greenfield & Sacks, P.C

Goods and services

What the mark covers

The products and services FIRVANQ is filed for, grouped by Nice class.

  • Antibiotics; pharmaceutical preparations, namely, vancomycin for the treatment of colitis and gastrointestinal disorders in oral solution form, powder form and diluent form; pharmaceutical preparations, namely, vancomycin for the treatment of clostridium difficile and staphylococcus aureus colitis in oral solution form, powder form and diluent form.

FAQ

About FIRVANQ

Who owns the trademark "FIRVANQ"?

The WIPO trademark "FIRVANQ" is owned by Azurity Pharmaceuticals, Inc.

What is the status of "FIRVANQ"?

Its status at the WIPO is: registered.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull FIRVANQ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_b866f03a-325b-4e60-afc0-5f439c7b0c75
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_b866f03a-325b-4e60-afc0-5f439c7b0c75",
  "object": "trademark",
  "mark_text": "FIRVANQ",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2025-04-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Azurity Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb725-e6a7-73db-81c8-7bbc8473b1bf"
    }
  ]
}